Lantheus price target lowered to $84 from $109 at B. Riley

B. Riley lowered the firm’s price target on Lantheus (LNTH) to $84 from $109 and keeps a Buy rating on the shares. The firm views the near-term risk for Lantheus as whether Pylarify further loses market share and that Pylarify will be surpassed by Illuccix/Gozellix before 2nd-generation Pylarify receives pass-through status in the second half of 2026, the analyst tells investors in a research note. The firm waits for a stabilization of the stock price and better visibility into the long-term growth prospects in the next 6-12 months.